1. Please check and comment entries here.
Table of Contents

    Topic review

    PAX6 Gene

    View times: 11
    Submitted by: Lily Guo
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    paired box 6

    1. Introduction

    The PAX6 gene belongs to a family of genes that play a critical role in the formation of tissues and organs during embryonic development. The members of the PAX gene family are also important for maintaining the normal function of certain cells after birth. To carry out these roles, the PAX genes provide instructions for making proteins that attach to specific areas of DNA and help control the activity (expression) of particular genes. On the basis of this action, PAX proteins are called transcription factors.

    During embryonic development, the PAX6 protein is thought to turn on (activate) genes involved in the formation of the eyes, the brain and spinal cord (central nervous system), and the pancreas. Within the brain, the PAX6 protein is involved in the development of a specialized group of brain cells that process smell (the olfactory bulb). Additionally, researchers believe that the PAX6 protein controls many aspects of eye development before birth. After birth, the PAX6 protein likely regulates the expression of various genes in many structures of the eyes.

    2. Health Conditions Related to Genetic Changes

    2.1. Aniridia

    More than 280 mutations in the PAX6 gene have been found to cause aniridia, which is an absence of the colored part of the eye (the iris). Most of these mutations create a premature stop signal in the instructions for making the PAX6 protein and lead to the production of an abnormally short, nonfunctional protein. As a result, there is less PAX6 protein to regulate the activity of other genes.

    The majority of mutations that cause aniridia occur within the PAX6 gene; however, some disease-causing mutations occur in neighboring regions of DNA that normally regulate the expression of the PAX6 gene, known as regulatory regions. Mutations in PAX6 gene regulatory regions reduce the expression of the PAX6 gene. These mutations lead to a shortage of functional PAX6 protein, which disrupts the formation of the eyes during development.

    2.2. Peters anomaly

    At least two mutations in the PAX6 gene have been found to cause Peters anomaly. This condition is characterized by the abnormal development of certain structures at the front of the eye and clouding of the clear front surface of the eye (cornea). The mutations that cause Peters anomaly change single protein building blocks (amino acids) in the PAX6 protein. These mutations reduce but do not eliminate the protein's function and are less severe than mutations that cause aniridia (described above). The mutations that cause Peters anomaly reduce the PAX6 protein's ability to bind to DNA, disrupting its role as a transcription factor. As a result, normal development of the eye is impaired, leading to the features of Peters anomaly. The PAX6 gene mutations that cause Peters anomaly can cause other related eye disorders in members of the same family.

    Coloboma

    Microphthalmia

     

    WAGR syndrome

    The PAX6 gene is located in a region of chromosome 11 that is deleted in people with WAGR syndrome, which is a disorder that affects many body systems and is named for its main features: a childhood kidney cancer known as Wilms tumor, an eye problem called anirida, genitourinary anomalies, and intellectual disability (formerly referred to as mental retardation). As a result of this deletion, affected individuals are missing one copy of the PAX6 gene in each cell. A loss of the PAX6 gene is associated with the characteristic eye features of WAGR syndrome, including aniridia, and may affect brain development.

    2.3. Other disorders

    Mutations in the PAX6 gene can cause eye problems other than aniridia and Peters anomaly. The mutations that cause these eye problems occur in one copy of the PAX6 gene in each cell. Most of these mutations change single amino acids in the PAX6 protein. These mutations reduce but do not eliminate the protein's normal function, impairing its role as a transcription factor.

    Individuals with these relatively mild PAX6 gene mutations may be born with pupils that are not centrally positioned in the eye (ectopia papillae), small eyes (microphthalmia), and underdeveloped optic nerves, structures that carry information from the eyes to the brain. Mild PAX6 mutations can also result in a gap or split in structures that make up the eye (coloboma) or an underdeveloped region at the back of the eye responsible for sharp central vision (the fovea). Additional conditions caused by these PAX6 gene mutations may be present at birth or develop later. These conditions may include a clouding of the lens of the eye (cataracts), involuntary eye movements (nystagmus), and inflammation of the front surface of the eye called the cornea (keratitis).

    It is unclear why the effects of some mutations in the PAX6 gene are limited to the eye, while other mutations affect the development of many parts of the body.

    3. Other Names for This Gene

    • AN
    • AN2
    • D11S812E
    • MGC17209
    • MGDA
    • paired box gene 6
    • paired box gene 6 isoform a
    • paired box gene 6 isoform b
    • PAX6_HUMAN

    This entry is adapted from https://medlineplus.gov/genetics/gene/pax6

    References

    1. Azuma N, Yamaguchi Y, Handa H, Tadokoro K, Asaka A, Kawase E, Yamada M.Mutations of the PAX6 gene detected in patients with a variety of optic-nervemalformations. Am J Hum Genet. 2003 Jun;72(6):1565-70.
    2. Chao LY, Huff V, Strong LC, Saunders GF. Mutation in the PAX6 gene in twentypatients with aniridia. Hum Mutat. 2000;15(4):332-9.
    3. Graziano C, D'Elia AV, Mazzanti L, Moscano F, Guidelli Guidi S, Scarano E,Turchetti D, Franzoni E, Romeo G, Damante G, Seri M. A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation. Am J MedGenet A. 2007 Aug 1;143A(15):1802-5.
    4. Hanson IM. PAX6 and congenital eye malformations. Pediatr Res. 2003Dec;54(6):791-6.
    5. Hingorani M, Williamson KA, Moore AT, van Heyningen V. Detailed ophthalmologicevaluation of 43 individuals with PAX6 mutations. Invest Ophthalmol Vis Sci. 2009Jun;50(6):2581-90. doi: 10.1167/iovs.08-2827.
    6. Robinson DO, Howarth RJ, Williamson KA, van Heyningen V, Beal SJ, Crolla JA.Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 casesreferred with aniridia. Am J Med Genet A. 2008 Mar 1;146A(5):558-69. doi:10.1002/ajmg.a.32209.
    7. Ticho BH, Hilchie-Schmidt C, Egel RT, Traboulsi EI, Howarth RJ, Robinson D.Ocular findings in Gillespie-like syndrome: association with a new PAX6 mutation.Ophthalmic Genet. 2006 Dec;27(4):145-9.
    8. Tzoulaki I, White IM, Hanson IM. PAX6 mutations: genotype-phenotypecorrelations. BMC Genet. 2005 May 26;6:27.
    9. van Heyningen V, Williamson KA. PAX6 in sensory development. Hum Mol Genet.2002 May 15;11(10):1161-7. Review.
    More

    Keywords